Effect of substitution on novel tricyclic HIV-1 integrase inhibitors

被引:40
|
作者
Fardis, Maria
Jin, Haolun
Jabri, Salman
Cai, Ruby Z.
Mish, Michael
Tsiang, Manuel
Kim, Choung U.
机构
[1] Gilead Sci Inc, Dept Med Chem, Foster City, CA 94404 USA
[2] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA
关键词
HIV; integrase; AIDS; dihydropyrrolo[3,4-g]quinolin-8-one; acquired immunodeficiency syndrome;
D O I
10.1016/j.bmcl.2006.05.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel tricyclic inhibitors of HIV-1 integrase enzyme was prepared. The effect of substitution at C-6 of the 9-hydroxy-6,7-dihydropyrrolo[3,4-glquinolin-8-one compounds was studied in vitro. Inhibitors with small side chains at C-6 were generally well tolerated by the enzyme, and the physicochemical properties of the inhibitors were improved by substitution of a small alkyl group at this position. A second series of analogs bearing a sulfamate at the C-5 position with various C-6 substituents were prepared to explore the interplay between the two groups. The SAR of the two classes are not parallel; modification at C-5 impacts the effect of substitutions at C-6. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4031 / 4035
页数:5
相关论文
共 50 条
  • [31] Design and discovery of HIV-1 integrase inhibitors
    Neamati, N
    Sunder, S
    Pommier, Y
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (11) : 487 - 498
  • [32] HIV-1 Integrase Strand Transfer Inhibitors
    Johns, Brian A.
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 263 - +
  • [33] Integrase inhibitors in the treatment of HIV-1 infection
    Powderly, William G.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2485 - 2488
  • [34] Clinical progress of HIV-1 integrase inhibitors
    Al-Mawsawi, Laith Q.
    Al-Safi, Rasha I.
    Neamati, Nouri
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (02) : 213 - 225
  • [35] Peptide HIV-1 Integrase Inhibitors from HIV-1 Gene Products
    Suzuki, Shintaro
    Urano, Emiko
    Hashimoto, Chic
    Tsutsumi, Hiroshi
    Nakahara, Toru
    Tanaka, Tomohiro
    Nakanishi, Yuta
    Maddali, Kasthuraiah
    Han, Yan
    Hamatake, Makiko
    Miyauchi, Kosuke
    Pommie, Yves
    Beutler, John A.
    Sugiura, Wataru
    Fuji, Hideyoshi
    Hoshino, Tyuji
    Itotani, Kyoko
    Nomura, Wataru
    Narumi, Tetsuo
    Yamamoto, Naoki
    Komano, Jun A.
    Tamamura, Hirokazu
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) : 5356 - 5360
  • [36] Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
    Meixenberger, Karolin
    Yousef, Kaveh Pouran
    Somogyi, Sybille
    Fiedler, Stefan
    Bartmeyer, Barbara
    von Kleist, Max
    Kuecherer, Claudia
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 157 - 157
  • [37] Update on HIV integrase inhibitors for the treatment of HIV-1 infection
    Max, Blake
    [J]. FUTURE VIROLOGY, 2019, 14 (10) : 693 - 709
  • [38] A Versatile and Practical Synthesis toward the Development of Novel HIV-1 Integrase Inhibitors
    Rinaldi, Marta
    Tintori, Cristina
    Franchi, Luigi
    Vignaroli, Giulia
    Innitzer, Anna
    Massa, Silvio
    Este, Jose A.
    Gonzalo, Encarna
    Christ, Frauke
    Debyser, Zeger
    Botta, Maurizio
    [J]. CHEMMEDCHEM, 2011, 6 (02) : 343 - 352
  • [39] Dynamic pharmacophore model optimization: Identification of novel HIV-1 integrase inhibitors
    Deng, JX
    Sanchez, T
    Neamati, N
    Briggs, JM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (05) : 1684 - 1692
  • [40] Hydrazide-containing inhibitors of HIV-1 integrase
    Zhao, H
    Neamati, N
    Sunder, S
    Hong, HX
    Wang, SM
    Milne, GWA
    Pommier, Y
    Burke, TR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 937 - 941